Immunological evaluation of the crevicular fluid in patients with gingivitis, periodontitis, and peri-implantitis: a 1-year cross-sectional study
DOI:
https://doi.org/10.33448/rsd-v10i13.20756Keywords:
Cytokines; Periodontal diseases; Gingival crevicular fluid; Peri-implantitis.Abstract
Objective: To assess the levels of IL-12, IL-15, IL-18, and IL-32 in the gingival crevicular fluid (GCF) and peri-implant crevicular fluid (PICF) in patients with gingivitis, periodontitis, and peri-implantitis before and one year after implant installation. Material and Methods: Forty-nine samples of GCF and PICF were collected from March 2018 to March 2019. The patients were classified: patients with gingivitis (n=7), patients with periodontitis (n=14), patients with peri-implantitis (n=4) and healthy patients (n=24). The crevicular fluid from the 49 patients was collected before implant installation (n=8) and one year after implant placement (n=8). The Enzyme-Linked Immunosorbent Assay (ELISA) was used to evaluate the levels of cytokines in crevicular fluid. Results: Patients with gingivitis, periodontitis, and peri-implantitis showed higher concentrations of IL-12, IL-15, IL-18, and IL-32 when compared with control group. In general, the levels of IL-12 and IL-15 increased when compared to the moments before and after implant installation. There was also an increase in the concentration of IL-18 in the control group volunteers after implant installation. Conclusion: The results and methodology of this study showed that there was no difference in the synthesis of IL-12, IL-15, IL-18, and IL-32 in healthy individuals or in those with periodontal injuries. However, there was an increase in the cytokines IL-12, IL-15, and IL-18 one year after implant installation, which would be increasing the inflammatory activity in peri-implantitis.
References
Ali, M., Yang, F., Plachokova, A. S., Jansen, J. A., & Walboomers, X. F. (2021). Application of specialized pro‐resolving mediators in periodontitis and peri‐implantitis: a review. European Journal of Oral Sciences, 129(1). 10.1111/eos.12759
Badolato, R; Ponzi, A.N.; Millesimo, M., Notarangelo, L. D., & Musso, T. Interleukin-15 (IL-15) induces IL-8 and monocyte chemotactic protein 1 production in human monocytes. Blood. 1997;90(7):2804-2809. https://0019-9567/98/$04.0010
Bannwart, C. F., Nakaira, E. T., Sartori, A., & Peraçoli, M. T. S. (2007). Interleukin-15: its role in microbial infections. Journal of Venomous Animals and Toxins Including Tropical Diseases, 13(3). 10.1590/s1678-91992007000300002
Berglundh, T., Armitage, G., Araujo, M. G., Avila-Ortiz, G., Blanco, J., Camargo, P. M., & Zitzmann, N. (2018). Peri-implant diseases and conditions: Consensus report of workgroup 4 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. Journal of Clinical Periodontology, 45, S286–S291. 10.1111/jcpe.12957
Buduneli, E., Genel, F., Atilla, G., & Kütükçüçler, N. (2003). Evaluation of p53, bcl-2, and Interleukin-15 Levels in Gingival Crevicular Fluid of Cyclosporin A-Treated Patients. Journal of Periodontology, 74(4), 506–511. 10.1902/jop.2003.74.4.506
Carson, W., & Caligiuri, M. A. (1998). Interleukin-15 as a potential regulator of the innate immune response. Brazilian Journal of Medical and Biological Research, 31(1), 1–9. 10.1590/s0100-879x1998000100001
Carson, W.E., Ross, M. E., Baiocchi, R. A., Marien, M.J., Boiani, N,, Grabstein, K; Caligiuri, M. A. (1995). Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. The Journal of Clinical Investigation. 96, 2578-82. 10.1172/JCI118321
Chapple, I. L. C., Mealey, B. L., Van Dyke, T. E., Bartold, P. M., Dommisch, H., Eickholz, P., & Yoshie, H. (2018). Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: Consensus report of workgroup 1 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. Journal of Clinical Periodontology, 45, S68–S77. 10.1111/jcpe.12940
Conti, P., Youinou, P., & Theoharides, T. C. (2007). Modulation of autoimmunity by the latest interleukins (with special emphasis on IL-32). Autoimmunity Reviews, 6(3), 131–137. 10.1016/j.autrev.2006.08.015
De Araújo, M. F., Etchebehere, R. M., de Melo, M. L. R., Beghini, M., Severino, V. O., de Castro Côbo, E., & de Lima Pereira, S. A. (2017). Analysis of CD15, CD57 and HIF-1α in biopsies of patients with peri-implantitis. Pathology - Research and Practice, 213(9), 1097–1101. 10.1016/j.prp.2017.07.020
De Mendonça, A. C., Santos, V. R., César-Neto, J. B., & Duarte, P. M. (2009). Tumor Necrosis Factor-Alpha Levels After Surgical Anti-Infective Mechanical Therapy for Peri-Implantitis: A 12-Month Follow-Up. Journal of Periodontology, 80(4), 693–699. 10.1902/jop.2009.080521
Escobar, G. F., Abdalla, D. R., Beghini, M., Gotti, V. B., Junior, V. R., Napimoga, M. H.; Ribeiro, B. M., Rodrigues, D. B. R.;, Nogueira, R. D., & de Lima Pereira, S.A. (2018). Levels of Pro and Anti-inflammatory Citokynes and C-Reactive Protein in Patients with Chronic Periodontitis Submitted to Nonsurgical Periodontal Treatment. Asian Pacific Journal of Cancer Prevention, 19(7), 1927-1933. 10.22034/APJCP.2018.19.7.1927
Figueredo, C. M., Rescala, B., Teles, R. P., Teles, F. P., Fischer, R. G., Haffajee, A. D., & Gustafsson, A. (2008). Increased interleukin-18 in gingival crevicular fluid from periodontitis patients. Oral Microbiology and Immunology, 23(2), 173–176. 10.1111/j.1399-302x.2007.00408.x
Goda, C., Kanaji, T., Kanaji, S., Tanaka, G., Arima, K., Ohno, S., & Izuhara, K. (2006). Involvement of IL-32 in activation-induced cell death in T cells. International Immunology, 18(2), 233–240. 10.1093/intimm/dxh339
Gorvel, L., Korenfeld, D., Tung, T., & Klechevsky, E. (2017). Dendritic Cell–Derived IL-32α: A Novel Inhibitory Cytokine of NK Cell Function. The Journal of Immunology, 199(4), 1290–1300. 10.4049/jimmunol.1601477
Green, M. R., & Sambrook, J. (2018). A Single-Step Method for the Simultaneous Preparation of DNA, RNA, and Protein from Cells and Tissues. Cold Spring Harbor Protocols. 2018(1), pdb.prot093500. 10.1101/pdb.prot093500
Hu, Z., Wu, D., Zhao, Y., Chen, S., & Li, Y. (2019). Inflammatory cytokine profiles in the crevicular fluid around clinical healthy dental implants compared to the healthy contralateral side during the early stages of implant function. Archives of Oral Biology, 104509. 10.1016/j.archoralbio.2019.10
Johnson, R. B., & Serio, F. G. (2005). Interleukin-18 Concentrations and the Pathogenesis of Periodontal Disease. Journal of Periodontology, 76(5), 785–790. 10.1902/jop.2005.76.5.785
Kalsi A., Moreno, F., & Petridis, H. (2021). Biomarkers associated with periodontitis and peri-implantitis: a systematic review. Journal of Periodontal & Implant Science, 51(1): 3–17. 10.5051/jpis.1902840142
Kim, S.-H., Han, S.-Y., Azam, T., Yoon, D.-Y., & Dinarello, C. A. (2005). Interleukin-32. Immunity, 22(1), 131–142. 10.1016/j.immuni.2004.12.003
Kormas, I., Pedercini, C., Pedercini, A., Raptopoulos, M., Alassy, H., & Wolff, L.F. (2020). Peri-Implant Diseases: Diagnosis, Clinical, Histological, Microbiological Characteristics and Treatment Strategies. A Narrative Review. Antibiotics. 9(11), 835. 10.3390/antibiotics9110835
Nakanishi, K., Yoshimoto, T., Tsutsui, H., & Okamura, H. (2001). Interleukin-18 regulates both Th1 and Th2 responses. Annual Review of Immunology, 19(1), 423–474. 10.1146/annurev.immunol.19.1.
Novick, D., Rubinstein, M., Azam, T., Rabinkov, A., Dinarello, C. A., & Kim, S.-H. (2006). Proteinase 3 is an IL-32 binding protein. Proceedings of the National Academy of Sciences, 103(9), 3316–3321. 10.1073/pnas.0511206103
Orozco, A., Gemmell, E., Bickel, M., & Seymour, G. J. (2006). Interleukin-1 beta, interleukin-12 and interleukin-18 levels in gingival fluid and serum of patients with gingivitis and periodontitis. Oral Microbiology and Immunology, 21(4), 256–260. 10.1111/j.1399-302x.2006.00292.x
Papapanou, P. N., Sanz, M., Buduneli, N., Dietrich, T., Feres, M., Fine, D. H., & Tonetti, M. S. (2018). Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. Journal of Clinical Periodontology, 45, S162–S170. 10.1111/jcpe.12946
Pradeep, A. R., Daisy, H., Hadge, P., Garg, G., & Thorat, M. (2009). Correlation of Gingival Crevicular Fluid Interleukin-18 and Monocyte Chemoattractant Protein-1 Levels in Periodontal Health and Disease. Journal of Periodontology, 80(9), 1454–1461. 10.1902/jop.2009.090117
Renvert, S., Persson, G. R., Pirih, F. Q., & Camargo, P. M. (2018). Peri-implant health, peri-implant mucositis, and peri-implantitis: Case definitions and diagnostic considerations. Journal of Clinical Periodontology, 45, S278–S285. 10.1111/jcpe.12956
Rinke, S., Nordlohne, M., Leha, A., Renvert, S., Schmalz, G., & Ziebolz, D. (2020). Risk indicators for mucositis and peri-implantitis: results from a practice-based cross-sectional study. Journal of Periodontal & Implant Science, 50(3), 183-196. 10.5051/jpis.2020.50.3.183
Romee, R., Rosario, M., Berrien-Elliott, M. M., Wagner, J. A., Jewell, B. A., Schappe, T., & Fehniger, T. A. (2016). Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia. Science Translational Medicine, 8(357), 357ra123–357ra123. 10.1126/scitranslmed.aaf2341
Sattler, A., Dang-Heine, C., Reinke, P., & Babel, N. (2015). IL-15 dependent induction of IL-18 secretion as a feedback mechanism controlling human MAIT-cell effector functions. European Journal of Immunology, 45(8), 2286–2298. 10.1002/eji.201445313
Schierano, G., Pejrone, G., Brusco, P., Trombetta, A., Martinasso, G., Preti, G., & Canuto, R. A. (2008). TNF-α TGF-β2 and IL-1β levels in gingival and peri-implant crevicular fluid before and after de novo plaque accumulation. Journal of Clinical Periodontology, 35(6), 532–538. 10.1111/j.1600-051x.2008.01224.x
Sgolastra, F., Petrucci, A., Severino, M., Gatto, R., & Monaco, A. (2013). Periodontitis, implant loss and peri-implantitis. A meta-analysis. Clinical Oral Implants Research, 26(4), e8–e16. 10.1111/clr.12319
Silva, N., Abusleme, L., Bravo, D., Dutzan, N., Garcia-Sesnich, J., Vernal, R., & Gamonal, J. (2015). Host response mechanisms in periodontal diseases. Journal of Applied Oral Science, 23(3), 329–355. 10.1590/1678-775720140259
Tonetti, M. S., Greenwell, H., & Kornman, K. S. (2018). Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. Journal of Clinical Periodontology, 45, S149–S161. 10.1111/jcpe.12945
Ussher, J. E., Bilton, M., Attwod, E., Shadwell, J., Richardson, R., de Lara, C., & Willberg, C. B. (2013). CD161++CD8+T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner. European Journal of Immunology, 44(1), 195–203. 10.1002/eji.201343509
Yoshikai, Y., & Nishimura, H. (2000). The role of interleukin 15 in mounting an immune response against microbial infections. Microbes and Infection, 2(4), 381–389. 10.1016/s1286-4579(00)00329-4
Zhang, X., Wang, Q., Yan, X., Shan, Y., Xing, L., Li, M., & Lai, W. (2020). Immune landscape of periodontitis unveils alterations of infiltrating immunocytes and molecular networks-aggregating into an interactive web-tool for periodontitis related immune analysis and visualization. Journal of Translational Medicine, 18(1). 10.1186/s12967-020-02616-1
Zhuang, L., Fulton, R. J., Rettman, P., Sayan, A. E., Coad, J., Al-Shamkhani, A., & Khakoo, S. I. (2018). Activity of IL-12/15/18 primed natural killer cells against hepatocellular carcinoma. Hepatology International, 13, 75–83. 10.1007/s12072-018-9909-3
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Juliana Barbosa de Faria; Taíssa Cássia de Souza Furtado; Thaís Soares Farnesi de Assunção; Douglas Reis Abdalla; Fabiane Minin Andrade; Bárbara Bellocchio Bertoldo; Eleonora de Paula Amaral; Denise Bertulucci Rocha Rodrigues; Virmondes Rodrigues Júnior; Sanivia Aparecida de Lima Pereira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
